Genzyme gets public backing for $200M expansion
Genzyme is getting some public backing for a $200 million expansion project in the south of Ireland. The Cambridge, MA-based biotech plans to hire about 170 people as it expands its manufacturing and research operations. Ireland has become a key global player in biopharma over the years, hosting a range of manufacturing and lab facilities. Teva announced its own expansion plans for Waterford last month.
- read the story from the International Herald Tribune
Related Articles:
Genzyme--Big Biotech's Stock Report. Report
Genzyme on buyouts: Thanks but no thanks. Report
Boston officials herald big Genzyme expansion. Report
Be the first to comment
Comments
Post new comment
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets